Redox Raised $33M in Series C Funding

Redox, a Madison, Wis.-primarily based organization that lets in healthcare carriers and software program vendors to share information digitally, closed a $33m Series C investment spherical.

The spherical was led through worldwide funding company Battery Ventures with participation from present investors .406 Ventures, RRE Ventures, and Intermountain Ventures. As a part of the transaction, Battery General Partner Chelsea Stoner, will be part of the Redox board.

Led through co-founder and CEO Luke Bonney, Redox hurries up the improvement and distribution of healthcare software program solutions with a full-service integration platform to safely and correctly change statistics.

Healthcare transport companies and technology vendors join once and authorize the statistics they ship and get hold of throughout the maximum enormous interoperable community in healthcare.

With Redox, software program developers allow smooth access thru an intuitive and standardized software programming interface (API). Its vendor-agnostic method lets in messages to be despatched or obtained securely in any layout related to an organization’s electronic health record (EHR).

Over 450 healthcare carriers and loads of cloud-primarily based programs use the Redox Interoperability Platform to change records with partners. Among them, AdventHealth, Atrium Health, Brigham & Women’s Hospital, Clarify Health, Cleveland Clinic, Geisinger, HCA, Healthgrades, Intermountain Healthcare, Invitae, Fitbit, Memorial Sloan Kettering, Microsoft, Ochsner, OSF HealthCare, PointClickCare, R1, ResMed, Stryker, UCSF, University of Pennsylvania, and WellStar.